Humana soars, Alignment Healthcare on Medicare rating changes
Humana shares rose 16.5% and Alignment Healthcare fell over 20% after Medicare Advantage Star Ratings were updated. Humana's largest contract improved to 4 stars, while Alignment's largest contract dropped to 3.5 stars. These ratings impact federal bonus payments and 2028 revenues.
How this was made
The 30-second read
Why it matters
The rating changes directly affect eligibility for federal quality bonus payments, influencing earnings outlook for 2028.
Market read
The article highlights a significant regulatory-driven move in the US health insurance sector, with immediate price impact on two insurers.
What to watch
Potential policy changes or CMS methodology revisions could affect future ratings.
Background
CMS released 2027 Medicare Advantage star ratings, causing Humana's rating to rise and Alignment's to fall, driving large stock moves.
Ticker impact
Humana surged 16.5% after CMS upgraded its star rating, restoring eligibility for quality bonus payments.
upward pressure as market prices in future bonus payments
The rating change directly increases expected cash flows, driving strong price appreciation.
Alignment Healthcare fell over 20% after CMS downgraded its star rating, losing eligibility for quality bonus payments.
downward pressure as loss of bonus reduces earnings outlook
The downgrade cuts expected federal payments, prompting a sharp sell-off.
Market effects
Rating changes could prompt revaluation of other Medicare Advantage insurers.
Impacts US health insurance sector.
Limited to US market.
Counterpoint
The rating upgrade may be temporary and market may price out the upside.
Key entities
- companyHumana
US health insurer whose rating was upgraded.
- companyAlignment Healthcare
US health insurer whose rating was downgraded.
- agencyCMS
Centers for Medicare & Medicaid Services, issuer of the star ratings.
